The Best Stock Funds of 2023

Driven by a rebound in large and megacap stocks, in particular the “Magnificent Seven” technology companies,…

Stocks Fall in New Year

The S&P 500 fell Wednesday, opening the new year with two consecutive days in the red.…

A Tale of Two Pharmas: Can Obesity Firms Continue Their Outperformance in 2024?

In pharma, you can take a larger slice of the healthcare pie than your peers, but…

Microsoft Tops the List of Best-Managed Companies of 2023

Journal Reports: Leadership What’s New in the Best Managed Companies Rankings in 2023 By Rick Wartzman…

Can a Big Pharma Ever Be Worth $1 Trillion?

There are five tech companies valued at over $1 trillion. In healthcare, the closest contender is…

Gene Editing Will Change Medicine—and Maybe Health Investing Too

It usually takes time for scientific discoveries in the lab to make their way to the…

Obesity Drugs Put These Stocks on a Crash Diet—Now They’re Rebounding

There is a bit of cognitive dissonance in healthcare investing right now. After reviewing the highly…

Stocks Continue to Rally, With Investors More Confident in a Soft Landing

Growing evidence of a gradually cooling economy helped push stocks higher once again Wednesday.  The S&P 500…

Stocks Snap Winning Streak After Powell Warns Inflation Victory Not Assured

The S&P 500’s shot at its longest winning streak since 2004 appeared within grasp for much…

Obesity Drug Demand Outstrips Supply

Eli Lilly’s blockbuster diabetes medication Mounjaro is expected to receive Food and Drug Administration approval as…